ArticleCureus2025
Maternal and Perinatal Outcomes in Oligohydramnios: A Cross-Sectional Analysis of Pregnancies Between 28 to 42 Weeks of Gestation.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Associated Factors for Cesarean Section in Pregnant Women with Gestational Diabetes Mellitus.International journal of women's health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Oligohydramnios, defined as an amniotic fluid index (AFI) <5 cm or a single deepest pocket <2 cm, is associated with increased risks of intrauterine growth restriction (IUGR), umbilical cord compression, and perinatal morbidity. Despite extensive research, controversy remains regarding the optimal management strategy for pregnancies complicated by oligohydramnios. This study evaluates maternal and perinatal outcomes in oligohydramnios to guide clinical decision-making. Methods A hospital-based cross-sectional study was conducted over two years (October 2022 to September 2024) at a tertiary care center. The study included 188 pregnant women between 28 and 42 weeks of gestation diagnosed with oligohydramnios. Data on maternal demographic characteristics, pregnancy complications, fetal monitoring parameters, mode of delivery, and neonatal outcomes were collected and analyzed using chi-square and t-tests, with a significance level of p<0.05. Results The study revealed significant maternal and perinatal complications in oligohydramnios. The mean maternal age was 25.4 ± 4.2 years, with 61.7% primigravida. Cesarean section was the predominant mode of delivery (69.1%) due to fetal distress. Low birth weight (<2.5 kg) occurred in 53.19% of neonates, with 29.73% having an Apgar score ≤7 at one minute. Neonatal intensive care unit (NICU) admission was required in 14.36% of cases, and perinatal mortality was 8.5%. Non-reactive non-stress tests (NST) (25.53%) and abnormal Doppler findings were strongly associated with adverse outcomes, highlighting the need for close fetal monitoring and timely intervention. Conclusion Oligohydramnios is associated with a high rate of operative deliveries, increased neonatal morbidity, and adverse perinatal outcomes. Early identification and close fetal monitoring using Doppler studies and NSTs play a critical role in optimizing pregnancy outcomes. The findings reinforce the need for individualized management strategies to improve neonatal survival and reduce maternal complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.